MARKET

AMED

AMED

Amedisys Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

115.38
+4.56
+4.11%
After Hours: 115.38 0 0.00% 16:01 07/05 EDT
OPEN
109.53
PREV CLOSE
110.82
HIGH
115.62
LOW
107.55
VOLUME
407.25K
TURNOVER
0
52 WEEK HIGH
276.21
52 WEEK LOW
101.61
MARKET CAP
3.76B
P/E (TTM)
19.89
1D
5D
1M
3M
1Y
5Y
Stifel Starts Amedisys at Hold With $128 Price Target
MT Newswires · 06/29 05:52
Amedisys' (AMED) New Tie Up to Boost At-Home Patient Care
Amedisys (AMED) strengthens its Home Health and Hospice business reach by partnering with Memorial Hermann.
Zacks · 06/28 15:20
Memorial Hermann and Contessa Partner to Provide Patients New At-Home Care Options
This partnership gives patients options of where to receive inpatient, rehabilitation, and palliative careHOUSTON and NASHVILLE, Tenn., June 24, 2022 (GLOBE NEWSWIRE) -- Memorial Hermann Health System is pleased to announce a new partnership with the natio...
GlobeNewswire · 06/24 12:30
67 Biggest Movers From Yesterday
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.
Benzinga · 06/22 08:49
Amedisys stock slumps 13% as Bofa trims rating on CMS proposed Medicare home health rate cut
Amedisys (NASDAQ:AMED) stock fell ~13% on June 21 after Bank of America downgraded the stock to Underperform from Neutral with a price target of $102, from $145, following Centers for
Seekingalpha · 06/21 16:34
Stephens & Co. Maintains Equal-Weight Rating for Amedisys: Here's What You Need To Know
Stephens & Co. has decided to maintain its Equal-Weight rating of Amedisys (NASDAQ:AMED) and lower its price target from $155.00 to $125.00. Shares of Amedisys are trading down 12.59% over the last 24 hours, at $106.09 per share.
Benzinga · 06/21 16:04
Analyst Ratings for Amedisys
Analysts have provided the following ratings for Amedisys (NASDAQ:AMED) within the last quarter:
Benzinga · 06/21 16:04
45 Stocks Moving In Tuesday's Mid-Day Session
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.
Benzinga · 06/21 16:03
More
No Data
Learn about the latest financial forecast of AMED. Analyze the recent business situations of Amedisys Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

17.65%Strong Buy
47.06%Buy
29.41%Hold
5.88%Under-perform
0.00%Sell
Analyst Price Target
The average AMED stock price target is 161.00 with a high estimate of 200.00 and a low estimate of 102.00.
High200.00
Average161.00
Low102.00
Current 115.38
EPS
Actual
Estimate
0.420.841.271.69
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 473
Institutional Holdings: 35.14M
% Owned: 107.88%
Shares Outstanding: 32.57M
TypeInstitutionsShares
Increased
124
2.90M
New
62
450.04K
Decreased
89
1.43M
Sold Out
55
947.00K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.13%
Healthcare Providers & Services
-1.31%
Key Executives
Non-Executive Chairman
Paul Kusserow
President/Chief Executive Officer/Director
Christopher Gerard
Chief Financial Officer/Executive Vice President
Scott Ginn
Chief Information Officer
Michael North
Chief Compliance Officer
Denise Bohnert
Other/IR Contact Officer
Nick Muscato
Other
David Kemmerly
Lead Director/Independent Director
Julie Klapstein
Independent Director
Vickie Capps
Independent Director
Molly Coye
Independent Director
Teresa Kline
Independent Director
Bruce Perkins
Independent Director
Jeffrey Rideout
Independent Director
Ivanetta Samuels
No Data
No Data
About AMED
Amedisys, Inc. is a healthcare services company, which is a multi-state provider of home health, hospice, and personal care services. The Company operates through three segments: Home Health, Hospice and Personal Care. The Home Health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with important personal tasks. The Hospice segment provides palliative care and comfort to terminally ill patients and their families. The Personal Care segment provides patients with assistance with the essential activities of daily living. The Company owns and operates approximately 320 Medicare-certified home health care centers, 180 Medicare-certified hospice care centers and approximately 14 personal-care care centers in 39 states within the United States and the District of Columbia.

Webull offers kinds of Amedisys Inc stock information, including NASDAQ:AMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMED stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMED stock methods without spending real money on the virtual paper trading platform.